SGLT2 Inhibitors in Gout - Better Outcomes, Fewer Meds Natalie McCormick, PhD (RACER Center, Mass General Brigham), led a new Diabetes Care study on gout-related medication use after starting SGLT2 inhibitors in patients with gout and type 2 diabetes. https://t.co/BFJB3OY2L3 https://t.co/63Bu4t6LYM